செல் சிகிச்சை சந்தித்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from செல் சிகிச்சை சந்தித்தல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In செல் சிகிச்சை சந்தித்தல் Today - Breaking & Trending Today

Fate Therapeutics Inc (FATE) Q1 2021 Earnings Call Transcript

Operator
Good day, ladies and gentlemen and welcome to the Fate Therapeutics First Quarter 2021 Financial Results Conference Call. This call is being webcast live on the Investors section of Fate Therapeutics website at fatetherapeutics.com. [Operator Instructions]
I will now turn the call over to Scott Wolchko, President and CEO of Fate Therapeutics. Scott, you may begin.
Scott Wolchko
President And Chief Executive Officer
Thank you. Good afternoon and thanks everyone for joining us for the Fate Therapeutics first quarter 2021 financial results call. Shortly after 4:00 p.m. Eastern Time today, we issued a press release with these results, which can be found on the Investors section of our website under Press Releases. In addition, our Form 10-Q for the quarter ended March 31, 2021 was filed shortly thereafter and can be found on the Investors section of our website under Financial Information. Before we begin, I would like to remind everyone that except for ....

United States , Robyn Karnauskas , Jeff Miller , Ted Tenthoff Piper Sandler , Alethia Young Cantor , Sarah Cooley , Alethia Young , Wayne Chu , Michael Yee , Peter Lawson , Edward Dulac , Yigal Nochomovitz , Scott Wolchko , Piper Sandler , Bob Valamehr , Sloan Kettering , Ed Dulac , Robyn Karnauskas Truist , Michael Yee Jefferies , Ted Tenthoff , Peter Lawson Barclays , Yigal Nochomovitz Citi , Development Officer , American Society Of Clinical Oncology Annual Meeting , Fate Therapeutics Inc , American Society Of Gene ,

Flexion Therapeutics Inc (FLXN) Q1 2021 Earnings Call Transcript

Flexion Therapeutics Inc (FLXN) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Flexion Therapeutics Inc (NASDAQ: FLXN)
Popular Searches
Operator
Good afternoon, ladies and gentlemen, and welcome to the Flexion Therapeutics Business Update Call. [Operator Instructions]
I will now turn the call over to Scott Young, Flexion s Vice President of Corporate Communications and Investor Relations.SPONSORED:
10 stocks we like better than Flexion Therapeutics
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,
Motley Fool Stock Advisor, has tripled the market. ....

United States , Dana Flanders Guggenheim , Daniel Busby , Raymond James , Gary Nachman , Graig Suvannavejh , Michael Clayman , Dan Busby , Martin Auster , Elliot Wilbur Raymond James , David Arkowitz , Francois Brisebois , Dana Flanders , Francois Brisebois Oppenheimer , Elliot Wilbur , Scott Young , Mike Clayman , Graig Suvannavejh Goldman Sachs , Department Of Defense , Goldman Sachs , Credit Suisse , Veterans Administration , Motley Fool Flexion Therapeutics Inc , Corporate Communications , Flexion Therapeutics Inc , Call Transcript ,

Flexion Therapeutics Inc (FLXN) Q1 2021 Earnings Call Transcript

Flexion Therapeutics Inc (FLXN) Q1 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

United States , Dana Flanders Guggenheim , Daniel Busby , Raymond James , Gary Nachman , Graig Suvannavejh , Michael Clayman , Dan Busby , Martin Auster , Elliot Wilbur Raymond James , David Arkowitz , Francois Brisebois , Dana Flanders , Francois Brisebois Oppenheimer , Elliot Wilbur , Scott Young , Mike Clayman , Graig Suvannavejh Goldman Sachs , Corporate Communications , Department Of Defense , Goldman Sachs , Credit Suisse , Flexion Therapeutics Inc , Veterans Administration , Flexion Therapeutics Business Update , Vice President ,